Zydus Pharmaceuticals (USA) Inc.
210 Carnegie Center
Suite 103
Princeton
New Jersey
08540
United States
Tel: 609-275-5125
Fax: 609-275-0499
Website: http://www.zydususa.com/
13 articles about Zydus Pharmaceuticals (USA) Inc.
-
Zydus Pharmaceuticals (USA) Inc. joins the End Drug Shortages Alliance
6/29/2022
Zydus Pharmaceuticals ( USA ) Inc., a wholly owned subsidiary of Zydus Lifesciences Ltd. announced that it has joined a new coalition of diverse stakeholders to address drug shortages in the United States.
-
The vaccine, dubbed ZyCoV-D, will be the first DNA vaccine available in the world if authorized by regulators.
-
Zydus' Desidustat shows efficacy and safety in treating Hypoxia in hospitalized COVID-19 patients in Mexico
1/25/2021
Novel mechanism of targeting 'hypoxia' through HIF-PH inhibitor was studied for the first time in Hospitalised Covid-19 Patients in Mexico
-
Supernus Announces Settlement With Zydus Pharmaceuticals (USA) Inc. On Trokendi XR Patent Litigation
3/7/2017
-
Supernus Pharmaceuticals Files Lawsuit Against Zydus Pharmaceuticals (USA) Inc. In U.S. Court For Infringement Of Patents Covering Its Antiepileptic Drug, Trokendi XR
11/25/2014
-
Supernus Pharmaceuticals Sues Zydus Pharmaceuticals (USA) Inc. For Infringement Of Trokendi XR(R) Patents
11/24/2014
-
Zydus Pharmaceuticals (USA) Inc. to Recall Single Lot of Warfarin After Complaints
6/13/2013
-
Somaxon Pharmaceuticals, Inc. Announces Settlement of Silenor Patent Litigation With Zydus Pharmaceuticals (USA) Inc.
7/19/2012
-
Zydus Pharmaceuticals (USA) Inc. Selects Revitas™ Flex™ Platform to Support Growth Model
5/3/2012
-
K-V Pharmaceutical Company to Divest Generics Business to Zydus Pharmaceuticals (USA) Inc. for $60 Million
6/17/2011
-
Shire plc Files Suit against Cadila Healthcare Limited, Doing Business As Zydus Cadila and Zydus Pharmaceuticals (USA) Inc.
7/12/2010
-
Cosmo Pharmaceuticals S.p.A. Reports Shire Pharmaceuticals Receives LIALDA(R) Paragraph IV Notice Letter from Zydus Pharmaceuticals (USA) Inc.
6/1/2010
-
Zydus Pharmaceuticals (USA) Inc. Announces FDA Final Approval for the Generic Version of Topamax(R) Tablets
3/30/2009